RegMed XB joins global life sciences leaders at WHX Osaka 2026
This Thursday, RegMed XB heads to Osaka for the WHX Osaka 2026 Roundtable & Workshop — a gathering of international life sciences cluster leaders asking one key question: what is the global standard for healthcare deep tech startup ecosystems?
Our General Director, Bernard Mulder, joins representatives from six clusters worldwide in a panel discussion exploring what it takes to build and scale healthcare deep tech, from regulatory pathways to international partnership models.
The event runs in two parts. The first, a Global Life Sciences Roundtable, brings cluster leaders together to share their approaches and compare what a world-class startup ecosystem looks like in practice. The second, a Global Life Sciences Cluster Workshop, zooms in on global expansion pathways — how clusters can help their startups connect and grow internationally.
RegMed XB participates alongside Nakanoshima Qross, Cell and Gene Therapy Catapult, Health Holland, Lead Discovery Center GmbH, Swissnex, Swiss Biotech Association, CIC, and MedTech Actuator — a reflection of just how international the healthcare deep tech conversation has become.
📅 Thursday, 2 July 2026 · 1:00–5:00 PM
📍 Osaka, Japan
We will share reflections and takeaways from the event in the days that follow.